Someone wanted a million shares …

Bump from the WSJ article

And now resumed ...

Trading halted

If you feel confident that news will come out in the next 38 days, you can buy a Jan put that will guarantee a sell price of $8. Only costs 85 cents per share.

Dec put is only $0.35, but only good for the next 10 days.

Any company that corners the market on truly effective treatments for hair loss and skin aging/wrinkles will be worth about a bazillion dollars.

Good catch.

He said Holy Name was participating in all the big clinical trials for therapeutics. I think the three he specifically mentioned were regeneron, remdesivir, and Pluristem. He said they were showing good results.

I believe PLX is being administered under an Expanded Access Program (EAP), not an Emergency Use Authorization (EUA).

You do that a lot ;)

That’s another Zack’s computer generated “article” which is really just an ad for their “Ultimate” membership (only $299 per month!)

Don’t believe me? Just Google the first sentence of the article (without the company name). You’ll get at least a dozen identical articles, all for different companies.

Also, take a look at the Wikipedia article on Betteridge’s Law of Headlines, which states “Any headline that ends in a question mark can be answered by the word No.”

I believe Benzinga incorrectly reported the total number of shares owned by Clover Wolf. The correct number is 3,987,589 as of yesterday, per the Form 4 filed today.

It looks like someone erred by adding the cumulative amount from 9/29 to the cumulative amount from 9/30. Both of those numbers are on the Form 4.

“Insiders” include anyone who owns at least 10%. Therefore, an insider is not necessarily a company officer.
From sec.gov:
“Transaction reporting by officers, directors and 10% shareholders
Section 16 of the Exchange Act applies to an SEC reporting company's directors and officers, as well as shareholders who own more than 10% of a class of the company's equity securities registered under the Exchange Act. The rules under Section 16 require these “insiders” to report most of their transactions involving the company's equity securities to the SEC within two business days on Forms 3, 4 or 5.”

I reserve the right to update my projections in the future as more information becomes available ;)

CLI trial results on Dec 31 and COVID trial results on Mar 31.

Lockdowns and Mask Mandates Do Not Lead to Reduced COVID Transmission Rates or Deaths, New Study Suggests


https://www.aier.org/article/lockdowns-and-mask-mandates-do-not-lead-to-reduced-covid-transmission-rates-or-deaths-new-study-suggests/

Okay, it makes sense that up until now patients were approved on an individual basis. But the FDA website still lists several criteria for the EAP that make it seem like it’s only used as a last resort.

https://www.fda.gov/news-events/public-health-focus/expanded-access

Well now I’m a little confused. From the press release today, and from prior news, I thought PSTI was already cleared for compassionate use in the US. However, from the FDA website, it seems FDA equates Expanded Access Program to Compassionate Use. So perhaps the EAP is not really an expansion of what has already been happening? Or maybe the expansion relates to the number of people that can be treated? :|

zzaatt,

I completely agree. Longs should be in for the long term, while recognizing that news could come at any moment. I, for one, am willing to risk bad news for the possibility of good news sending the stock skyward.

A minor point of clarification: today’s news was for an Expanded Access Program, not compassionate use (which was already in effect). As I understand it, compassionate use is only for patients who have not responded to any approved treatment and are facing imminent death. The EAP, on the other hand, allows any patient access to the treatment, if they don’t qualify for the Phase II study. This should be a much larger eligible population (though apparently only 100 will be treated).

Gary,
Here’s an interesting opinion piece that provides a counterpoint to your argument. Let me know what you think.

https://www.redstate.com/michael_thau/2020/08/24/lockdown-monumental-mistake-–-must-not-happen-again-says-top-uk-epidemiologistcovid-advisor/

Funny how “rumors” pop up right before option expiration day. Here’s my prediction: no news on Friday.

Yes, it’s in the Wall Street Journal, so that counts for something. But it’s on the OPINION page, and it’s written not by a WSJ news reporter but by an industry person who has a *vested interest* in convincing people he’s right. It would have had much more impact if it had been news.

Your ignorance is showing. Price per share is meaningless for comparing companies. Ford is worth $27 billion. GE is worth $57 billion.

Another reason the PLX-PAD trial is important:

More Britons have been killed by flu and pneumonia than coronavirus for seven weeks in a row, new data reveals

https://www.dailymail.co.uk/news/article-8617795/More-Britons-killed-flu-pneumonia-coronavirus-seven-weeks.html

zzaatt,
There is no evidence of any manipulation of stock price. Some people think this stock should be higher than it is, therefore someone must be keeping the price down. I’m sure you know this is a highly speculative investment. Big risk = big potential reward. The stock price reflects the market assessment of the risk/reward.

Or if you want, you can believe that “big pharma” is paying Canadians to naked-short this stock. Which of course would be highly illegal and extremely risky.

BTW, I’m long from ~$4 and have a sizable investment in PSTI.

Why would anyone buy a stock that’s being controlled??

Gary, there have been 45 events in the CLI trial. Nothing has been published about events in the COVID trial.

I know exactly what naked short selling is. You’re the one who said “there are no shares being traded therefore no money to be made”. I can assure you people are making money with this approach. And some are losing money.

And you haven’t answered a single one of my questions or provided any evidence that would support your claims.

Please post any evidence you have that a specific pharma company is paying Canadians to do naked short selling of PSTI.

I’d settle for a link to ANYONE on the internet claiming a specific company is paying Canadians to do this.

You’re wrong. Naked shorting is *selling* shares that don’t exist, so that you can later buy them at a (hopefully) lower price, thereby MAKING MONEY. Naked short selling is very risky. Do you think these people aren’t doing it to make money?

Okay, show of hands: How many of you believe this statement —

”In Naked Short Selling There Are NO SHARES Being Traded Therefore No Money To Be Made !”

That doesn’t make sense. Short sellers want the price to go to zero. If “Big Pharma” makes an offer for PSTI, it will be significantly above the current price and short sellers will get screwed. Besides, as long as the board can issue another 30 million shares, there will be no takeover without board approval of the price. Short sellers, naked or otherwise, want this company to go under.

Also, how do you know people are naked short selling PSTI? How many naked shares are outstanding now? Is it a significant number compared to the total number of outstanding shares? How much lower is the price now than it would be if no one was selling short naked? If you can’t answer those questions then how are your claims (specifically about PSTI) believable?

So I guess we all benefited from these folks who kept the price down when we bought our shares. Thank you short sellers! (Or do they only keep the price down when we want to sell?!?)

Please tell me who can manipulate a stock in which millions of dollars trade hands daily, and there are multiple MMs and ECNs. In other words, how much money would I need to keep the stock price below (or above) a certain price?

Okay, sorry. I thought you were implying stock price manipulation.

What do you mean by “manipulation”?

First, the $75 million sale of new stock may not happen right away.

Second, even if it does, what if the proceeds are used to establish or expand production capability in anticipation of successful completion of one or more of the trials? That would be positive, right?

If they know at least one of the trials is going well, wouldn’t they be planning now to hit the ground running when it completes?

Not surprised the price is dropping a bit, given that now we don’t expect to hear anything on the COVID trial before October. Let’s see if our institutional friends take advantage and load up.

caltrials, what was the horrible news that was supposed to be coming over the weekend?

That link you posted is for a computer-generated clickbait article. There are literally dozens of articles with nearly identical wording that say the same thing about other companies. There is nothing in that article that is specific to PSTI, nor is there any significant new information about PSTI.